What happened: Dr. Jitendra Singh urged wider awareness of the Rs 1 lakh crore RDI Fund
Union Minister for Science & Technology Dr. Jitendra Singh urged greater awareness and stakeholder outreach about the Rs 1 lakh crore Research, Development and Innovation (RDI) Fund. Dr. Jitendra Singh asked that eligible applicants understand the Fund’s purpose, eligibility, and the process for availing support. Dr. Jitendra Singh said that large numbers of applications show a need for clearer communication because some applicants do not appear to understand the Fund’s nature and purpose.
Dr. Jitendra Singh cautioned against a common misunderstanding that the RDI Fund is simply another source of finance or a conventional loan facility. Dr. Jitendra Singh stated that the RDI Fund is meant to support technology development and research that contributes to progress of science and research and to overall growth of the national economy.
Dr. Jitendra Singh stated that the funding process is transparent with proper safeguards. Dr. Jitendra Singh also said the government remains open to suggestions for further safeguards wherever feasible.
Background: TDB’s outreach and lab-to-market translation goal
Dr. Jitendra Singh highlighted the Technology Development Board (TDB) role in educating intended stakeholders about the RDI Fund. Dr. Jitendra Singh emphasized that as technology and policy frameworks change, stakeholder mindsets must also change.
Related current affairs
- TDB-DST supports commercialization of indigenous Agentic AI platform by One2X Tech
- RDI Fund conflict-of-interest policy protected by stringent safeguards; stakeholder inputs sought; disbursal and SLFM selection underway
- TDB-DST extends financial assistance to OrthoGraft for commercialization of advanced tissue-derived biological dressings for wound care
- Tasers to ‘Tavis’ request/feature: Taxing “Tanjung”: Research capital and India academy funding dependence
- Jitendra Singh seeks enhanced private sector participation in India’s biotechnology ecosystem through BIRAC-RDIF
- TDB-DST supports Griva Healthcare for commercialization of indigenous AI-powered cervical cancer screening technology (GrivaVision)
